Sanara Medtech (SMTI) had the highest return in 1991 by a US stock in the Nasdaq Composite (IXIC), returning 114,483.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Sanara Medtech (SMTI) | 1991 | 114,483.33% |
BioLife Solutions (BLFS) | 1991 | 765.98% |
Biomerica (BMRA) | 1991 | 652.87% |
Shyft (SHYF) | 1991 | 591.58% |
Jack Henry & Associates (JKHY) | 1991 | 555.37% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Mesa Laboratories (MLAB) | 1991 | 361.54% |
Lisata Therapeutics (LSTA) | 1991 | 329.27% |
Veru (VERU) | 1991 | 325.4% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Bio-Techne (TECH) | 1991 | 303.95% |
Electronic Arts (EA) | 1991 | 302.6% |
Educational Development (EDUC) | 1991 | 299.4% |
Plexus (PLXS) | 1991 | 289.75% |
Celldex Therapeutics (CLDX) | 1991 | 282.61% |
Merit Medical Systems (MMSI) | 1991 | 274.31% |
Bel Fuse A (BELFA) | 1991 | 268.42% |
Amgen (AMGN) | 1991 | 266.53% |
PTC (PTC) | 1991 | 254.41% |
Advanced Micro Devices (AMD) | 1991 | 250% |
RadNet (RDNT) | 1991 | 231.58% |
Vaxart (VXRT) | 1991 | 231.25% |
Genesis Healthcare (GEN) | 1991 | 229.66% |
